The analysis named the 25 U.S. life science startups most likely to go public, including a Denver-based diabetes treatment ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Five U.S. consumer groups and two big labor unions are pushing for the Federal Trade Commission to block Novo Nordisk ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...

First, bariatric surgery added two quality-adjusted life years and saved patients about $9,000 more each year compared to GLP-1s. Second, combining surgery and GLP-1s led to more benefits, with ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

U.S. Public Interest Research Group, Service Employees International Union (SEIU) and others expressed concerns in a letter ...

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting ...

Wisp, a virtual provider of sexual and reproductive health services, is launching a new weight care vertical to help women ...